INS and type 2 diabetes mellitus: The results of BEYOND seem to confute the dogma about the inevitability and eternity of basal-bolus regimen in type 2 diabetes [11] by presenting the evidence around the feasibility and safety to switch either to a once-daily injection of a FRC or once-daily gliflozin pill added to basal insulin.